Occult hepatitis B virus and hepatitis C virus infections
Tóm tắt
Occult HBV infection is a well‐recognised clinical entity characterised by the detection of HBV‐DNA in serum and/or in liver in the absence of detectable hepatitis B surface antigen (HBsAg). Occult HBV infection has been described not only in patients who have resolved an acute or chronic HBV infection but also in patients without any serological markers of a past HBV infection. Occult HBV infection in patients with chronic HCV infection may induce more severe liver disease and lower response rate to interferon treatment. The existence of occult HCV infections has been also reported more recently. Occult HCV infection is characterised by the presence of HCV‐RNA in liver and peripheral blood mononuclear cells in the absence of detectable serum HCV‐RNA. Occult HCV infection may occur under two different clinical situations: in hepatitis C antibody‐(anti‐HCV) negative and serum HCV‐RNA‐negative patients with abnormal liver function tests and in anti‐HCV‐positive patients who have no detectable serum HCV‐RNA and who have normal liver enzymes. The clinical relevance of occult HCV infections is still under investigation. Copyright © 2008 John Wiley & Sons, Ltd.
Từ khóa
Tài liệu tham khảo
Magnius LO, 1975, A new antigen‐antibody system. Clinical significance in long‐term carriers of hepatitis B surface antigen, J Am Med Assoc, 231, 356, 10.1001/jama.1975.03240160020020
Cabrerizo M, 1997, Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen‐negative hemodialysis patients and staff, J Am Soc Nephrol, 8, 1143, 10.1681/ASN.V891443
Di Bisceglie AM, 1995, Long‐term outcome of interferon‐alpha therapy for chronic hepatitis B, J Hepatol, 22, 65
Oguchi H, 1992, Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units, Clin Nephrol, 38, 36
Ferraro D, 2003, Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C, J Biol Regul Homeost Agents, 17, 172
Hou J, 1995, A unique insertion in the S gene of surface antigen‐negative hepatitis B virus Chinese carriers, Hepatology, 21, 273
Koziel MJ, 2005, Cellular immune responses against hepatitis C virus, Clin Infect Dis, 41, S25, 10.1086/429492
Bartendchlager R, 2000, Replication of hepatitis C virus, J GenVirol, 81, 1631
Scognamiglio P, 1999, Presence of effector CD8+1; T cells in hepatitis C virus‐exposed healthy seronegative donors, J Immunol, 162, 6681, 10.4049/jimmunol.162.11.6681